A long-awaited study of the first new tuberculosis vaccine in nearly a century shows that it offers no significant advantage over the existing vaccine in protecting babies from TB infections. The results, based on a study of about 3,000 babies in South Africa, were disappointing but not a complete surprise. The vaccine, called MVA85A, is the most advanced of more than a dozen TB vaccines now in human clinical trials. Scientists are still trying to assess why the trial failed and how these ...
No comments:
Post a Comment